The post New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development appeared on BitcoinEthereumNews.com. Gary K. Zammit, PhD, releases “Beyond the Science” with Forbes Books. FORBES BOOKS NEW YORK (November 18, 2025) — Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences by Gary K. Zammit, PhD, is now available on Amazon and at major booksellers. The book is published with Forbes Books, the exclusive business book publishing imprint of Forbes. In Beyond the Science, Gary Zammit, an award-winning entrepreneur and founder of Clinilabs, offers an insider’s guide to what makes clinical research organizations thrive or fail. Backed by over twenty-five years of experience, Dr. Zammit reveals how the success of drug and device development depends not only on innovative science but also on the people, processes, and systems behind it. The book shares Dr. Zammit’s experience building Clinilabs, a specialty contract research organization dedicated to central nervous system therapeutics. Readers follow the company’s story from its early struggles through near-collapse during the Great Recession to its emergence as a highly respected industry leader. Along the way, Dr. Zammit emphasizes that true breakthroughs require assembling teams of “A-players,” creating processes that blend scientific rigor with practical efficiency, and leveraging systems that enable people to excel. Structured in two parts, the book first examines how leaders can foster cultures that inspire innovation, collaboration, and integrity. In the second part, Dr. Zammit outlines the operational frameworks that drive excellence in clinical trials from risk mitigation and compliance to integrating new technologies. Combining his hard-earned lessons with insights from industry peers, Dr. Zammit’s compendium assembles leaders and entrepreneurs committed to pushing the boundaries of medical research. “While this book focuses on the life sciences—the industry I know—I believe that the concepts presented can be applied to just about any business enterprise,” Dr. Zammit said. “In the end, people, processes, and systems must… The post New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development appeared on BitcoinEthereumNews.com. Gary K. Zammit, PhD, releases “Beyond the Science” with Forbes Books. FORBES BOOKS NEW YORK (November 18, 2025) — Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences by Gary K. Zammit, PhD, is now available on Amazon and at major booksellers. The book is published with Forbes Books, the exclusive business book publishing imprint of Forbes. In Beyond the Science, Gary Zammit, an award-winning entrepreneur and founder of Clinilabs, offers an insider’s guide to what makes clinical research organizations thrive or fail. Backed by over twenty-five years of experience, Dr. Zammit reveals how the success of drug and device development depends not only on innovative science but also on the people, processes, and systems behind it. The book shares Dr. Zammit’s experience building Clinilabs, a specialty contract research organization dedicated to central nervous system therapeutics. Readers follow the company’s story from its early struggles through near-collapse during the Great Recession to its emergence as a highly respected industry leader. Along the way, Dr. Zammit emphasizes that true breakthroughs require assembling teams of “A-players,” creating processes that blend scientific rigor with practical efficiency, and leveraging systems that enable people to excel. Structured in two parts, the book first examines how leaders can foster cultures that inspire innovation, collaboration, and integrity. In the second part, Dr. Zammit outlines the operational frameworks that drive excellence in clinical trials from risk mitigation and compliance to integrating new technologies. Combining his hard-earned lessons with insights from industry peers, Dr. Zammit’s compendium assembles leaders and entrepreneurs committed to pushing the boundaries of medical research. “While this book focuses on the life sciences—the industry I know—I believe that the concepts presented can be applied to just about any business enterprise,” Dr. Zammit said. “In the end, people, processes, and systems must…

New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development

Gary K. Zammit, PhD, releases “Beyond the Science” with Forbes Books.

FORBES BOOKS

NEW YORK (November 18, 2025)Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences by Gary K. Zammit, PhD, is now available on Amazon and at major booksellers. The book is published with Forbes Books, the exclusive business book publishing imprint of Forbes.

In Beyond the Science, Gary Zammit, an award-winning entrepreneur and founder of Clinilabs, offers an insider’s guide to what makes clinical research organizations thrive or fail. Backed by over twenty-five years of experience, Dr. Zammit reveals how the success of drug and device development depends not only on innovative science but also on the people, processes, and systems behind it.

The book shares Dr. Zammit’s experience building Clinilabs, a specialty contract research organization dedicated to central nervous system therapeutics. Readers follow the company’s story from its early struggles through near-collapse during the Great Recession to its emergence as a highly respected industry leader. Along the way, Dr. Zammit emphasizes that true breakthroughs require assembling teams of “A-players,” creating processes that blend scientific rigor with practical efficiency, and leveraging systems that enable people to excel.

Structured in two parts, the book first examines how leaders can foster cultures that inspire innovation, collaboration, and integrity. In the second part, Dr. Zammit outlines the operational frameworks that drive excellence in clinical trials from risk mitigation and compliance to integrating new technologies. Combining his hard-earned lessons with insights from industry peers, Dr. Zammit’s compendium assembles leaders and entrepreneurs committed to pushing the boundaries of medical research.

“While this book focuses on the life sciences—the industry I know—I believe that the concepts presented can be applied to just about any business enterprise,” Dr. Zammit said. “In the end, people, processes, and systems must work together seamlessly for greatness to be possible.”

At its core, Beyond the Science argues that R&D must be more than research and development—it must also be about revolt and disruption.

This release is posted on behalf of Forbes Books (operated by Advantage Media Group under license).

About the Author

Gary Zammit, PhD, is founder and CEO of Clinilabs, and an award-winning entrepreneur and expert in neuropsychiatric drug development and sleep medicine. A clinical professor at the Icahn School of Medicine at Mount Sinai and Fellow of the American Academy of Sleep Medicine, he has dedicated his career to developing better treatments for patients with psychiatric and neurological disorders.

About Forbes Books

Founded in 2016 in partnership with Advantage Media Group, Forbes Books is the exclusive book publishing imprint of Forbes Media. Forbes Books offers business and thought leaders a way to share their ideas and expertise with the world. Authors are carefully vetted to ensure their stories and insights align with the Forbes mission of driving success through innovation and entrepreneurial thinking. For more information, visit books.forbes.com.

Forbes Books Media Contact: Tate Causey, [email protected]

Source: https://www.forbes.com/sites/forbes-books-news/2025/11/18/new-book-shows-how-the-right-culture-and-strategy-drive-breakthroughs-in-drug-and-device-development/

Market Opportunity
Sidekick Logo
Sidekick Price(K)
$0.008692
$0.008692$0.008692
+108.39%
USD
Sidekick (K) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

A Netflix ‘KPop Demon Hunters’ Short Film Has Been Rated For Release

A Netflix ‘KPop Demon Hunters’ Short Film Has Been Rated For Release

The post A Netflix ‘KPop Demon Hunters’ Short Film Has Been Rated For Release appeared on BitcoinEthereumNews.com. KPop Demon Hunters Netflix Everyone has wondered what may be the next step for KPop Demon Hunters as an IP, given its record-breaking success on Netflix. Now, the answer may be something exactly no one predicted. According to a new filing with the MPA, something called Debut: A KPop Demon Hunters Story has been rated PG by the ratings body. It’s listed alongside some other films, and this is obviously something that has not been publicly announced. A short film could be well, very short, a few minutes, and likely no more than ten. Even that might be pushing it. Using say, Pixar shorts as a reference, most are between 4 and 8 minutes. The original movie is an hour and 36 minutes. The “Debut” in the title indicates some sort of flashback, perhaps to when HUNTR/X first arrived on the scene before they blew up. Previously, director Maggie Kang has commented about how there were more backstory components that were supposed to be in the film that were cut, but hinted those could be explored in a sequel. But perhaps some may be put into a short here. I very much doubt those scenes were fully produced and simply cut, but perhaps they were finished up for this short film here. When would Debut: KPop Demon Hunters theoretically arrive? I’m not sure the other films on the list are much help. Dead of Winter is out in less than two weeks. Mother Mary does not have a release date. Ne Zha 2 came out earlier this year. I’ve only seen news stories saying The Perfect Gamble was supposed to come out in Q1 2025, but I’ve seen no evidence that it actually has. KPop Demon Hunters Netflix It could be sooner rather than later as Netflix looks to capitalize…
Share
BitcoinEthereumNews2025/09/18 02:23
Adam Wainwright Takes The Mound Again Honor Darryl Kile

Adam Wainwright Takes The Mound Again Honor Darryl Kile

The post Adam Wainwright Takes The Mound Again Honor Darryl Kile appeared on BitcoinEthereumNews.com. Adam Wainwright of the St. Louis Cardinals in the dugout during the second inning against the Miami Marlins at Busch Stadium on July 18, 2023 in St. Louis, Missouri. (Photo by Brandon Sloter/Image Of Sport/Getty Images) Getty Images St. Louis Cardinals lifer Adam Wainwright is a pretty easygoing guy, and not unlikely to talk with you about baseball traditions and barbecue, or even share a joke. That personality came out last week during our Zoom call when I mentioned for the first time that I’m a Chicago Cubs fan. He responded to the mention of my fandom, “So far, I don’t think this interview is going very well.” Yet, Wainwright will return to Busch Stadium on September 19 on a more serious note, this time to honor another former Cardinal and friend, the late Darryl Kile. Wainwright will take the mound not as a starting pitcher, but to throw out the game’s ceremonial first pitch. Joining him on the mound will be Kile’s daughter, Sierra, as the two help launch a new program called Playing with Heart. “Darryl’s passing was a reminder that heart disease doesn’t discriminate, even against elite athletes in peak physical shape,” Wainwright said. “This program is about helping people recognize the risks, take action, and hopefully save lives.” Wainwright, who played for the St. Louis Cardinals as a starting pitcher from 2005 to 2023, aims to merge the essence of baseball tradition with a crucial message about heart health. Kile, a beloved pitcher for the Cardinals, tragically passed away in 2002 at the age of 33 as a result of early-onset heart disease. His sudden death shook the baseball world and left a lasting impact on teammates, fans, and especially his family. Now, more than two decades later, Sierra Kile is stepping forward with Wainwright to…
Share
BitcoinEthereumNews2025/09/18 02:08
Two Prime selected to manage $250 million in bitcoin for Digital Wealth Partners

Two Prime selected to manage $250 million in bitcoin for Digital Wealth Partners

The institutional bitcoin manager expands its mandate as demand for professional risk-managed digital asset strategies grows.
Share
Coinstats2026/01/16 18:00